pre-update Archives

On-Demand Webinar

Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors

It is crucial for biotech developers to engage in early commercial market assessment to generate…

Certara2021年3月5日

Article

Scientific Computing World: Connecting Science

Interconnection is an imperative for the modern laboratory, and seamless integration is mandatory from the…

Certara2021年3月4日

White Paper

Simcyp PBPK を用いた小児用医薬品開発の促進

Certara2021年3月4日

On-Demand Webinar

Quantitative Systems Pharmacology for Drug Discovery and Development

Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…

Certara2021年3月2日

Press Release

Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe

Broadens European footprint with integrated regulatory services and statistical analysis PRINCETON, NJ.— 2021年3月2日–…

Certara2021年3月2日

Blog

The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers

By: James Zoshak The COVID-19 pandemic has added increased risk and uncertainty to gene therapy…

Certara2021年2月22日

Brochure

Gene Therapy Platform using Certara’s Virtual Twin™

Certara2021年2月22日

Blog

遺伝子治療を患者へ届けるために

This blog discusses the challenges that drug developers face in getting patients access to cell…

Certara2021年2月16日

Blog

なぜ患者の安全性に関する説明には一貫性が必要なのか

“You would not be able to tell 40 different writers were authoring these. It looked…

Certara2021年2月9日

Publication

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

Certara2021年2月9日

pre-update

Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors

Scientific Computing World: Connecting Science

Simcyp PBPK を用いた小児用医薬品開発の促進

Quantitative Systems Pharmacology for Drug Discovery and Development

Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe

The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers

Gene Therapy Platform using Certara’s Virtual Twin™

遺伝子治療を患者へ届けるために

なぜ患者の安全性に関する説明には一貫性が必要なのか

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

メルマガ登録

クイックアクセス

ソリューション

お問合せ